
==== Front
BioimpactsBioimpactsBioImpactsBioImpacts : BI2228-56522228-56602228-5652Tabriz University of Medical Sciences 10.15171/bi.2019.08CorrectionCorrection: A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model Mookerjee Ananda 
1
$&Graciotti Michele 
2
$Kandalaft Lana E. 
1

2
*
1 Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, USA

2 Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland; Department of Oncology, University Hospital of Lausanne, Lausanne, Switzerland
* Corresponding author: Lana E. Kandalaft, Email: lana.kandalaft@chuv.ch$ These authors equally contributed.
& Currently at: Cardiovascular Research Center, Icahn School of Medicine, Mount Sinai, New York, USA
2019 12 1 2019 12 1 2019 9 1 65 65 © 2019 The Author(s)2019
This work is published by BioImpacts as an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited.
https://bi.tbzmed.ac.ir
==== Body
This corrects the article "A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model" published on 2018: Volume 08, Issue 03, Pages 211-221.



Correction to: BioImpacts 10.15171/bi.2018.24, published on 2018: Volume 08, Issue 03



The original version of this article contained a typographical error in the spelling of the author Lana E. Kandalaft, which was incorrectly given as Lana Kandalaft. This has now been corrected in the PDF and HTML versions of the article.

